Results 131 to 140 of about 139,558 (270)

Changes in use of antiretroviral therapy in regions of Europe over time

, 1998
Ole Kirk, Amanda Mocroft, Terese L. Katzenstein, Adriano Lazzarin, Francisco Antunes, P Francioli, Ray P. Brettle, Jacqueline Parkin, Juan Gonzales-Lahoz, Jens Lundgren   +9 more
openalex   +1 more source

Advances in the Role of Antimicrobial Peptides in the Management of Sexually Transmitted Infections

Journal of Clinical Laboratory Analysis, Volume 39, Issue 11, June 2025.
The article reviews recent advancements in the use of antimicrobial peptides (AMPs) for the treatment and prevention of sexually transmitted infections (STIs), with a particular focus on research progress in combating infections such as gonorrhea, HIV, HSV, and Chlamydia, as well as the challenges and future directions in this field.
Shuangwen Xiao, Wei Zuo, Qing Xiang, Yafeng Xie, Yongjian Xiao   +4 more
wiley   +1 more source

Factors That Predict Incomplete Virological Response to Protease Inhibitor‐Based Antiretroviral Therapy [PDF]

, 1999
Lisa Clough, Erika M. C. D’Agata, Stephen Raffanti, David W. Haas   +3 more
openalex   +1 more source

Analytical treatment interruption among women with HIV in southern Africa who received VRC01 or placebo in the Antibody Mediated Prevention Study: ATI stakeholder engagement, implementation and early clinical data

Journal of the International AIDS Society, Volume 28, Issue 6, June 2025.
Abstract Introduction Antiretroviral therapy (ART) prevents and treats, but does not eradicate, HIV. Early ART initiation is associated with post‐ART virologic control, particularly among African women, and anti‐HIV‐1 broadly neutralizing antibodies (bnAbs) may modulate immune responses to HIV.
Shelly Karuna, Fatima Laher, Sufia Dadabhai, Pei‐Chun Yu, Doug Grove, Catherine Orrell, Joseph Makhema, Mina C. Hosseinipour, Carrie‐Anne Mathew, William Brumskine, Nyaradzo Mgodi, Philip Andrew, Lucio Gama, Carissa Karg, Gail Broder, Kagisho Baepanye, Jonathan Lucas, Michele Andrasik, Simbarashe Takuva, Manuel Villaran, Azwidihwi Takalani, Randall Tressler, Lydia Soto‐Torres, Amanda S. Woodward Davis, Ames Dhai, Ian M. Sanne, Myron S. Cohen, Lawrence Corey, Glenda Gray, Allan C. deCamp, Katharine J. Bar   +30 more
wiley   +1 more source

Impact of antiretroviral combination therapies on AIDS surveillance reports in Switzerland

, 1998
Martin Gebhardt, Martin Rickenbach, Matthias Egger   +2 more
openalex   +1 more source

Measuring mobility in HIV research in sub‐Saharan Africa: a scoping review

Journal of the International AIDS Society, Volume 28, Issue 6, June 2025.
Abstract Introduction Mobility—from overnight travel to permanent migration—can reduce service access and increase HIV risk, driving the epidemic in sub‐Saharan Africa (SSA). This scoping review described mobility measures used in HIV research to identify gaps and guide research on mobility to strengthen HIV responses in SSA.
Aleya Khalifa, Sara Wallach, M. Kate Grabowski, Dustin T. Duncan, Fred Nalugoda, Quarraisha Abdool Karim, Barun Mathema   +6 more
wiley   +1 more source

DECLINE IN HIV-ASSOCIATED KAPOSI'S SARCOMA (KS) AND NON-HODGKIN'S LYMPHOMA (NHL) FOLLOWING THE INTRODUCTION OF HIGHLY ACTIVE ANTIRETROVIRAL THERAPY (HAART).

, 1999
Charles L. Wiggins, David M. Aboulafia, Lennox M. Ryland, Susan E. Buskin, Sharon G. Hopkins, David B. Thomas   +5 more
openalex   +1 more source

Quantitative molecular monitoring of human immunodeficiency virus type 1 activity during therapy with specific antiretroviral compounds [PDF]

, 1995
Maria Carla Re, Stefano Menzo, A Valenza, Stefania Paolucci, S Petroni, Giorgio Scalise, Riccardo Sampaolesi, Aldo Manzin, Pietro E. Varaldo, Massimo Clementi   +9 more
openalex   +1 more source

Postnatal prophylaxis and the use of presumptive HIV therapy for the prevention of vertical transmission of HIV in Canada 1997–2020

Journal of the International AIDS Society, Volume 28, Issue 6, June 2025.
Abstract Introduction Presumptive HIV therapy (PHT) is recommended for post‐natal HIV prophylaxis (PNP) in situations at high risk of HIV vertical transmission (VT), for both prevention of transmission and as early treatment in cases of in utero transmission.
Jeanne Brochon, Terry Lee, Jason Brophy, Joel Singer, Marie‐Elaine Metras, Jeannette Comeau, Alena Tse‐Chang, Athena McConnell, Deborah Money, Isabelle Boucoiran, Laura J. Sauve, Ari Bitnun, Fatima Kakkar   +12 more
wiley   +1 more source

The Need for the Optimization of HIV Antiretroviral Therapy in Kazakhstan. [PDF]

Viruses
Mustafa A, Dzissyuk N, Bayserkin B, Begimbetova D, Nugmanova Z, Ali S.   +5 more
europepmc   +1 more source